Carol Grad, Legal Representative

Title: Carol Grad - Innovator in Cancer Detection and Treatment

Introduction

Carol Grad is a distinguished legal representative and inventor based in Thornhill, CA. She has made significant contributions to the field of cancer detection and treatment through her innovative work. With a focus on developing monoclonal antibodies, her research aims to improve the diagnosis and treatment of various neoplastic diseases.

Latest Patents

Carol Grad holds a patent for "Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for prophylaxis and detection of cancers." This invention relates to the monoclonal antibody H11 and its antigen binding fragments, which specifically bind to the C-antigen found on neoplastic cells. The patent outlines the effectiveness of the H11 antibody in diagnosing, localizing, and treating neoplasias, including melanoma, neuroblastoma, glioma, soft tissue sarcoma, and small cell lung carcinoma. The invention also provides methods for treating neoplastic diseases and reducing the risk of recurrence in patients who are in remission from traditional cancer therapies.

Career Highlights

Carol has been instrumental in her role at Viventia Biotech Inc., where she collaborates with other talented professionals in the field. Her work has not only advanced the understanding of cancer biology but has also paved the way for new therapeutic approaches.

Collaborations

Throughout her career, Carol has worked alongside notable colleagues, including Michael D. Dan and Pradip K. Maiti. Their combined expertise has contributed to the success of various projects aimed at improving cancer treatment options.

Conclusion

Carol Grad's innovative contributions to cancer detection and treatment exemplify her commitment to advancing medical science. Her work continues to inspire and pave the way for future breakthroughs in oncology.